|1.||Manning, Michael E: 2 articles (01/2014 - 05/2013)|
|2.||Fitts, David: 2 articles (01/2014 - 05/2013)|
|3.||Baker, James: 1 article (01/2014)|
|4.||Jacobson, Kraig W: 1 article (01/2014)|
|5.||Davis-Lorton, Mark A: 1 article (01/2014)|
|6.||Li, Henry: 1 article (01/2014)|
|7.||Lumry, William R: 1 article (01/2014)|
|8.||White, Martha V: 1 article (01/2014)|
|9.||Gower, Richard G: 1 article (01/2014)|
|10.||Bernstein, Jonathan A: 1 article (01/2014)|
09/01/2011 - "Cinryze and other similar products are going to change the future management of hereditary angioedema and have potential in other areas of medicine."
09/01/2011 - "Cinryze is a pasteurized, nanofiltered plasma derived concentrate of C1-inhibitor (pdC1-INH) licensed for the prophylactic treatment of hereditary angioedema. "
09/01/2011 - "Cinryze (C1-inhibitor) for the treatment of hereditary angioedema."
01/01/2010 - "Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety."
05/01/2013 - "To evaluate the use of Cinryze (nanofiltered C1-esterase inhibitor [C1 INH-nf]) for the acute management and prevention of hereditary angioedema attacks in the subgroup of children and adolescents who participated in 2 placebo-controlled and 2 open-label extension studies. "
|2.||Rare Diseases (Rare Disease)
|3.||Thrombocytopenic Purpura (Thrombopenic Purpura)
10/01/2009 - "In this article, you'll learn about six new drugs, including: * clevidipine, an I.V. antihypertensive for use when oral medication isn't feasible * romiplostim and eltrombopag olamine, new agents for chronic immune thrombocytopenic purpura * C1 inhibitor (human) for hereditary angioedema. "
|1.||Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)